Horizon Pharma plc to Participate in Upcoming Conferences
DUBLIN--(BUSINESS WIRE)--Nov 16, 2018--Horizon Pharma plc (Nasdaq: HZNP) announced today that the company will participate in the following conferences:
30 th Annual Piper Jaffray Healthcare ConferenceDate: Nov. 28, 2018 Presentation Time: 9 a.m. ET Location: New York, N.Y.
Bank of America Merrill Lynch 2018 Leveraged Finance ConferenceDate: Dec. 4, 2018 Presentation Time: 10:50 a.m. ET Location: Miami, Fla.
BMO 2018 Prescriptions for Success Healthcare ConferenceDate: Dec. 12, 2018 Presentation Time: 11:20 a.m. ET Location: New York, N.Y.
The conference presentations will be webcast live and may be accessed by visiting Horizon’s website at http://ir.horizon-pharma.com. A replay of the webcasts will be available for the events.
About Horizon Pharma plc
Horizon Pharma plc is focused on researching, developing and commercializing innovative medicines that address unmet treatment needs for rare and rheumatic diseases. By fostering a growing pipeline of medicines in development and exploring all potential uses for currently marketed medicines, we strive to make a powerful difference for patients, their caregivers and physicians. For us, it’s personal: by living up to our own potential, we are helping others live up to theirs. For more information, please visit www.horizonpharma.com, follow us @HZNPplc on Twitter or like us on Facebook.
View source version on businesswire.com:https://www.businesswire.com/news/home/20181116005066/en/
Senior Vice President,
Executive Vice President,
Corporate Affairs & Chief Communications Officer
KEYWORD: UNITED STATES EUROPE NORTH AMERICA FLORIDA NEW YORK IRELAND
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL GENERAL HEALTH
SOURCE: Horizon Pharma plc
Copyright Business Wire 2018.
PUB: 11/16/2018 08:00 AM/DISC: 11/16/2018 08:00 AM